Recorded Chinese product: 氯硝西泮注射液氯硝西泮注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司
主要成分Active Ingredients
- 氯唑西林钠Lvzuo Xilin Na
药物知识说明
氯唑西林钠是一种在国家药监局注册认定的药品。该药品含有氯唑西林钠-5e816696等成分。
该药品关联的活性成分包括：氯唑西林钠Lvzuo Xilin Na。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司。
您可以探索含有相同成分的其他药品：氯唑西林钠-5e816696成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 氯硝西泮注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 氯唑西林钠Lvzuo Xilin Na.
Manufacturers recorded for this product: 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司.
Explore other medicines containing the same ingredient: 氯唑西林钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 氯硝西泮注射液Recorded Chinese product: 氯硝西泮注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 1ml：lmg1 mL:lmg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10900003
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10900003
Manufacturer
Chinese legal name: 徐州莱恩药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10900003
生产企业
徐州莱恩药业有限公司(国产)
适应症
主要用于控制各型癫痫，尤适用于失神发作、婴儿痉挛症、肌阵挛性、运动不能性发作及Lennox-Gastaut综合症。
用法用量
用量应根据患者具体情况而个体化，尽量避免肌注。控制癫痫持续状态可用静脉注射，成人常用量1-4mg，30秒左右缓慢注射完毕，如持续状态仍未控制，每隔20分钟后可重复原剂量1～2次。成人最大量每日不超过20mg。
不良反应
1.常见的不良反应：嗜睡、头昏、共济失调、行为紊乱异常兴奋、神经过敏易激惹(反常反应)、肌力减退。2.较少发生的有行为障碍、思维不能集中、易暴怒（儿童多见）、精神错乱、幻觉、精神抑郁；皮疹或过敏、咽痛、发热或出血异常、淤斑、或极度疲乏、乏力（血细胞减少）。3.需注意的有：行动不灵活、行走不稳、嗜睡，开始严重，会逐渐消失；视力模糊、便秘、腹泻、眩晕或头晕、头痛、气管分泌增多、恶心、排尿障碍、语言不清。
禁忌
孕妇、妊娠期妇女、新生儿禁用。
贮藏
遮光，密闭保存。
规格
1ml：lmg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.